Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | RAB9A, member RAS oncogene family | Starlite/ChEMBL | No references |
Homo sapiens | myeloid cell leukemia 1 | Starlite/ChEMBL | No references |
Homo sapiens | polymerase (DNA directed), eta | Starlite/ChEMBL | No references |
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | sphingomyelin phosphodiesterase 1, acid lysosomal | Starlite/ChEMBL | No references |
Homo sapiens | huntingtin | Starlite/ChEMBL | No references |
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Homo sapiens | lysine (K)-specific demethylase 4E | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | ras-related protein Rab-5B | RAB9A, member RAS oncogene family | 201 aa | 165 aa | 30.9 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0071 | 0.0246 | 0.0229 |
Schistosoma mansoni | jumonji domain containing protein | 0.0071 | 0.0246 | 0.0229 |
Leishmania major | DNA polymerase eta, putative | 0.0054 | 0.0165 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.0185 | 0.0167 |
Echinococcus multilocularis | EGFP:Bcl2 fusion protein | 0.01 | 0.0384 | 0.0368 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.0885 | 0.0869 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0052 | 0.0034 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0052 | 0.5 |
Schistosoma mansoni | sodium-bile acid cotransporter related | 0.211 | 1 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.0017 | 0.5 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0071 | 0.0246 | 0.0229 |
Echinococcus granulosus | dna polymerase eta | 0.0054 | 0.0165 | 0.0147 |
Echinococcus granulosus | EGFP:Bcl2 fusion protein | 0.01 | 0.0384 | 0.0368 |
Brugia malayi | hypothetical protein | 0.0286 | 0.1272 | 0.1272 |
Brugia malayi | Apoptosis regulator proteins, Bcl-2 family protein | 0.01 | 0.0384 | 0.0384 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0023 | 0.0017 | 0.5 |
Brugia malayi | jmjC domain containing protein | 0.0071 | 0.0246 | 0.0246 |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.211 | 1 | 1 |
Echinococcus multilocularis | geminin | 0.0205 | 0.0885 | 0.0869 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0023 | 0.0017 | 0.5 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0023 | 0.0017 | 0.5 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0071 | 0.0246 | 0.0229 |
Schistosoma mansoni | hypothetical protein | 0.01 | 0.0384 | 0.0368 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0052 | 0.2319 |
Onchocerca volvulus | Huntingtin homolog | 0.0148 | 0.0614 | 0.0437 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.0596 | 0.0579 |
Entamoeba histolytica | Acid sphingomyelinase-like phosphodiesterase, putative | 0.01 | 0.0383 | 1 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0979 | 0.4591 | 0.4581 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0071 | 0.0246 | 0.0229 |
Schistosoma mansoni | sodium-bile acid cotransporter related | 0.0856 | 0.3999 | 0.3989 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0054 | 0.0165 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.0614 | 0.0597 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.0017 | 0.5 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0071 | 0.0246 | 0.0229 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.0596 | 0.0579 |
Echinococcus granulosus | sodium bile acid cotransporter | 0.211 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.0165 | 0.0147 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0023 | 0.0017 | 0.0017 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.0885 | 0.0869 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.0383 | 0.0366 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.0052 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.01 | 0.0384 | 0.0368 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0038 | 0.0088 | 1 |
Onchocerca volvulus | Huntingtin homolog | 0.0148 | 0.0614 | 0.0437 |
Schistosoma mansoni | apoptosis regulator bax | 0.01 | 0.0384 | 0.0368 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.0384 | 0.0368 |
Schistosoma mansoni | bcl-2 homologous antagonist/killer (bak) | 0.01 | 0.0384 | 0.0368 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0071 | 0.0246 | 0.0229 |
Echinococcus granulosus | Bcl 2 ous antagonist:killer | 0.01 | 0.0384 | 0.0368 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.0185 | 0.0167 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.1272 | 0.1257 |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.211 | 1 | 1 |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.211 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.0614 | 0.0597 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.0185 | 0.0185 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.1272 | 0.1257 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0023 | 0.0017 | 0.5 |
Loa Loa (eye worm) | apoptosis regulator protein | 0.01 | 0.0384 | 0.0368 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0052 | 0.5 |
Schistosoma mansoni | sodium-bile acid cotransporter | 0.1254 | 0.5907 | 0.59 |
Schistosoma mansoni | hypothetical protein | 0.01 | 0.0384 | 0.0368 |
Echinococcus multilocularis | Bcl 2 ous antagonist:killer | 0.01 | 0.0384 | 0.0368 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0054 | 0.0165 | 0.0165 |
Brugia malayi | hypothetical protein | 0.003 | 0.0052 | 0.0052 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0052 | 0.2319 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0054 | 0.0165 | 1 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.0052 | 0.2319 |
Leishmania major | DNA polymerase eta, putative | 0.0038 | 0.0088 | 0.4775 |
Loa Loa (eye worm) | hypothetical protein | 0.211 | 1 | 1 |
Schistosoma mansoni | DNA polymerase eta | 0.0054 | 0.0165 | 0.0147 |
Echinococcus granulosus | geminin | 0.0205 | 0.0885 | 0.0869 |
Entamoeba histolytica | Acid sphingomyelinase-like phosphodiesterase, putative | 0.01 | 0.0383 | 1 |
Echinococcus multilocularis | dna polymerase eta | 0.0054 | 0.0165 | 0.0147 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.0596 | 0.0596 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.1272 | 0.1257 |
Brugia malayi | jmjC domain containing protein | 0.0071 | 0.0246 | 0.0246 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.0052 | 0.2319 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0071 | 0.0246 | 0.0229 |
Giardia lamblia | DINP protein human, muc B family | 0.0023 | 0.0017 | 0.5 |
Brugia malayi | hypothetical protein | 0.0148 | 0.0614 | 0.0614 |
Echinococcus granulosus | sodium bile acid cotransporter | 0.211 | 1 | 1 |
Echinococcus granulosus | sodium bile acid cotransporter | 0.211 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0038 | 0.0088 | 0.4775 |
Onchocerca volvulus | 0.211 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 2.109717268 um | PUBCHEM_BIOASSAY: Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors. (Class of assay: confirmatory) [Related pubchem assays: 1022 (Primary screen preceding this dose-response assay.)] | ChEMBL. | No reference |
IC50 (functional) | 30.65 uM | PubChem BioAssay. Dose response confirmation of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (binding) | = 40 uM | Inhibition of BLM (unknown origin) by gel-based DNA unwinding assay | ChEMBL. | 24012121 |
IC50 (functional) | 80 uM | PubChem BioAssay. Dose response confirmation of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, in an orthogonal absorbance-based assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.4147 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 1 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 1.9953 um | PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ] | ChEMBL. | No reference |
Potency (functional) | 3.6626 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 3.9811 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | = 6.3096 um | PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.0795 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.9433 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.929 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.